Since it has been shown that activation of c-MYC also contributes to chemotherapy resistance in CRC [56], the c-MYC/AP4/miR-22-3p/MDC1 feed-forward loop characterized here is an attractive, new molecular mechanism, which explains chemotherapy resistance in CRC with elevated c-MYC expression. The gene discussed is MDC1; the disease is colorectal carcinoma.